Poletto E - Search Results

1

Effect of genistein and coenzyme Q10 in oxidative damage and mitochondrial membrane potential in an attenuated type II mucopolysaccharidosis cellular model.

Delgado CA, Poletto E, Vera LNP, Jacques CED, Vianna P, Reinhardt LS, Baldo G, Vargas CR. Delgado CA, et al. Among authors: poletto e. Cell Biochem Funct. 2024 Mar;42(2):e3932. doi: 10.1002/cbf.3932. Cell Biochem Funct. 2024. PMID: 38332678

2

Evaluation of oxidative stress and mitochondrial function in a type II mucopolysaccharidosis cellular model: in vitro effects of genistein and coenzyme Q10.

Jacques CED, Lopes FF, Poletto E, Vera LNP, Vianna P, Reinhardt LS, Baldo G, Vargas CR. Jacques CED, et al. Among authors: poletto e. Metab Brain Dis. 2023 Feb;38(2):519-529. doi: 10.1007/s11011-022-01062-w. Epub 2022 Aug 27. Metab Brain Dis. 2023. PMID: 36029429

3

Creating cell lines for mimicking diseases.

Poletto E, Baldo G. Poletto E, et al. Prog Mol Biol Transl Sci. 2021;181:59-87. doi: 10.1016/bs.pmbts.2021.01.014. Epub 2021 Feb 26. Prog Mol Biol Transl Sci. 2021. PMID: 34127202

4

Neonatal nonviral gene editing with the CRISPR/Cas9 system improves some cardiovascular, respiratory, and bone disease features of the mucopolysaccharidosis I phenotype in mice.

Schuh RS, Gonzalez EA, Tavares AMV, Seolin BG, Elias LS, Vera LNP, Kubaski F, Poletto E, Giugliani R, Teixeira HF, Matte U, Baldo G. Schuh RS, et al. Among authors: poletto e. Gene Ther. 2020 Feb;27(1-2):74-84. doi: 10.1038/s41434-019-0113-4. Epub 2019 Dec 11. Gene Ther. 2020. PMID: 31827259

5

Genome Editing for Mucopolysaccharidoses.

Poletto E, Baldo G, Gomez-Ospina N. Poletto E, et al. Int J Mol Sci. 2020 Jan 13;21(2):500. doi: 10.3390/ijms21020500. Int J Mol Sci. 2020. PMID: 31941077 Free PMC article. Review.

6

Evidence for inflammasome activation in the brain of mucopolysaccharidosis type II mice.

Azambuja AS, Pimentel-Vera LN, Gonzalez EA, Poletto E, Pinheiro CV, Matte U, Giugliani R, Baldo G. Azambuja AS, et al. Among authors: poletto e. Metab Brain Dis. 2020 Oct;35(7):1231-1236. doi: 10.1007/s11011-020-00592-5. Epub 2020 Jul 4. Metab Brain Dis. 2020. PMID: 32623553

7

Brain and visceral gene editing of mucopolysaccharidosis I mice by nasal delivery of the CRISPR/Cas9 system.

Vera LNP, Schuh RS, Fachel FNS, Poletto E, Piovesan E, Kubaski F, Couto E, Brum B, Rodrigues G, Souza H, Giugliani R, Matte U, Baldo G, Teixeira HF. Vera LNP, et al. Among authors: poletto e. J Gene Med. 2022 Apr;24(4):e3410. doi: 10.1002/jgm.3410. Epub 2022 Jan 31. J Gene Med. 2022. PMID: 35032067

8

Intra-articular nonviral gene therapy in mucopolysaccharidosis I mice.

Bidone J, Schuh RS, Farinon M, Poletto É, Pasqualim G, de Oliveira PG, Fraga M, Xavier RM, Baldo G, Teixeira HF, Matte U. Bidone J, et al. Among authors: poletto e. Int J Pharm. 2018 Sep 5;548(1):151-158. doi: 10.1016/j.ijpharm.2018.06.049. Epub 2018 Jun 27. Int J Pharm. 2018. PMID: 29940298

9

In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system.

Schuh RS, Poletto É, Pasqualim G, Tavares AMV, Meyer FS, Gonzalez EA, Giugliani R, Matte U, Teixeira HF, Baldo G. Schuh RS, et al. Among authors: poletto e. J Control Release. 2018 Oct 28;288:23-33. doi: 10.1016/j.jconrel.2018.08.031. Epub 2018 Aug 28. J Control Release. 2018. PMID: 30170069

10

Comment on "report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I".

Poletto E, Matte U, Baldo G. Poletto E, et al. BMC Med Genet. 2018 Oct 4;19(1):180. doi: 10.1186/s12881-018-0697-3. BMC Med Genet. 2018. PMID: 30286738 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page